The lack of sensitivity in CF testing was a prime factor in leading the NIH Workshop on Population Screening for the Cystic Fibrosis Gene to advocate that no mass programmes of heterozygote ...
In 1997, the National Institutes of Health convened a Consensus Development Conference on Cystic Fibrosis (CF). 1 The Consensus Conference recommended that genetic screening for CF mutations ...